I farmacisti ospedalieri pronti a dare il loro contributo per una gestione sicura ed efficiente dei vaccini anti-Covid. In una nota, la Società italiana di farmacia ospedaliera e dei servizi farmaceutici delle aziende sanitarie (Sifo) fa il punto su stoccaggio, conservazione appropriata e distribuzione. E assicura alle istituzioni tutta la collaborazione necessaria affinché il nostro Paese non si faccia trovare
La crisi sanitaria causata da Covid-19 dimostra la necessità di modernizzare il modo in cui l’Ue fornisce i medicinali alla sua popolazione. Pesa l'eccessiva dipendenza da Paesi terzi per alcuni principi attivi e medicinali essenziali. Per essere meno vulnerabile, il Vecchio Continente ha bisogno di una sua "infrastruttura autonoma".
L’Unione europea dalla salute serve. L’Europa adotti un approccio unitario “unitario e integrato” alle sfide sanitarie. A partire da una strategia comune per i farmaci e per la lotta al cancro.
Tra gli esperti è abbastanza diffusa la percezione che il Fondo per gli oncologici innovativi abbia contribuito a ridurre i tempi necessari per accedere alle nuove terapie anticancro, ma viene richiamata l’importanza di misurare tali effetti, se possibile, attraverso i dati di registro in cui i consumi sono distinti per indicazione.
Background: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. Methods: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (200 mg loading
Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in children, most children experience no/mild symptoms, and hospitalization and mortality rates are low in the age group. As symptoms are usually mild and seroconversion occurs at low frequencies, it remains unclear whether children significantly contribute to community transmission. Several hypotheses try to explain age-related differences in disease presentation and severity. Possible reasons
Objective: The development of oncology day-hospital activities contributes to increase quality of life of patients and consequently have changed their perception about waiting. The extemporaneous preparation of antineoplastic has become difficult to achieve given the increasing activity, and hospital pharmacists have taken up the challenge by the implementation of the antineoplastic preparation in anticipation. Because anticipation can lead to an important
Introduction: Although consistent use of tyrosine kinase inhibitors (TKIs) confers significant improvements in long-term survival for individuals with chronic myeloid leukemia (CML), only 70% of CML patients are adherent to TKIs. Understanding the factors that contribute to non-adherence and establishing dynamic adherence patterns in this population are essential aspects of targeted drug monitoring and intervention strategies. Methods: Newly diagnosed CML patients were identified
Background: The list of oral and expensive chemotherapy agents has lengthened over the last few years and has created unique medication adherence concerns. In a real-life setting, patients often do not take their medications as prescribed. This pattern is associated with poor outcomes and increased health care costs. Objectives: To estimate the adherence to oral anticancer chemotherapies and to determine the
Background: Patients with haematological malignancies are at high risk of invasive fungal infections. However, there is a lack of information about the utilisation of the recommended Australian antifungal prophylaxis guidelines in haematology outpatients. Objective: To assess the impact of a weekly pharmacist review of high-risk adult haematology outpatients on the utilisation of appropriate antifungal prophylaxis. Setting: Outpatient cancer centre, tertiary referral hospital in
